2nd Quarter - Report

U.S. PUBLIC INTEREST RESEARCH GROUP for U.S. PUBLIC INTEREST RESEARCH GROUP

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

3 June 2021 In my capacity as U.S. co-chair of the TransAtlantic Consumer Dialogue (TACD.org), signed a letter to President Joe Biden and European Commission President Ursula von der Leyen urging swift enactment of a TRIPS waiver to enable rapid production of Covid-19 vaccines worldwide.

LobbyistCovered position, as disclosed
EDMUND M MIERZWINSKI —

Contacted: Treasury, Dept of; HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); SENATE; Food & Drug Administration (FDA); White House Office; Federal Reserve System; Federal Trade Commission (FTC); Securities & Exchange Commission (SEC); Consumer Product Safety Commission (CPSC); Federal Deposit Insurance Corporation (FDIC); U.S. Trade Representative (USTR); Office of the Comptroller of the Currency (OCC)

Banking BAN

30 June 2021 (Signed by President and became Public Law No: 117-24 on this date. Supported S.J.Res.15 in House and Senate to legislatively repeal by Congressional Review Act an OCC rule enabling predatory lenders to rent bank charters and evade state usury ceilings. 12 May 2021 Supported H.R. 2570, the Climate Risk Disclosure Act (Casten) 16 April 2021 Signed debt collection reform group letter on H.R. 2547, the Comprehensive Debt Collection Improvement Act (Waters), which includes: HR__, the Small Business Fairness Lending Act (Velazquez), HR 1491, the Fair Debt Collection Practices for Servicemembers Act (Dean), HR 2498, the Private Loan Disability Discharge Act (Dean), HR 2537, the Consumer Protection for Medical Debt Collections Act (Tlaib), HR 1657, the Ending Debt Collection Harassment Act (Pressley), HR 2572, the Stop Debt Collection Abuse Act (Cleaver), HR __, the Debt Collection Practices Harmonization Act (Meeks), HR 2458, the Non-Judicial Foreclosure Debt Collection Clarification Act (Auchincloss). 6 May 2021 Joined group letter to CFPB Acting Director Requesting that CFPB Prohibit Credit Reporting of Rent Arrears Incurred During COVID-19 Pandemic Generally supported Fair Credit Reporting Act and Fair Debt Collection Practices Act improvements in phone calls and meetings with hill and agency staff, including H.R. 4120, the Comprehensive Consumer Credit Reporting Reform Act.

LobbyistCovered position, as disclosed
EDMUND M MIERZWINSKI —

Contacted: Office of the Comptroller of the Currency (OCC); White House Office; Labor, Dept of (DOL); SENATE; Consumer Product Safety Commission (CPSC); Treasury, Dept of; Federal Deposit Insurance Corporation (FDIC); Securities & Exchange Commission (SEC); Federal Reserve System; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Food & Drug Administration (FDA)

Bills named: H.R. 2572 (117th), H.R. 4120 (117th), H.R. 2498 (117th), H.R. 1491 (117th), H.R. 2570 (117th), H.R. 2547 (117th), H.R. 2537 (117th), H.R. 2458 (117th), H.R. 1657 (117th), S.J.Res. 15 (117th)

Financial Institutions/Investments/Securities FIN

6 May 2021 Joined group letter to Labor Department commending its issuance of Guidance and other steps to begin to rescind Trump Administration's so-called Improving Investment Advice for Worker & Retirees.

LobbyistCovered position, as disclosed
EDMUND M MIERZWINSKI —

Contacted: Federal Reserve System; Securities & Exchange Commission (SEC); SENATE; Consumer Product Safety Commission (CPSC); White House Office; Federal Deposit Insurance Corporation (FDIC); Food & Drug Administration (FDA); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Labor, Dept of (DOL); Treasury, Dept of; Office of the Comptroller of the Currency (OCC); HOUSE OF REPRESENTATIVES

Health Issues HCR

Met with Rep. Krishnamoorthi's office about writing a letter to the CDC about establishing a PPE clearinghouse. Lobbied several congressional offices on the Baby Food Safety Act (HR 2229), pitching them on co-sponsoring it. Lobbied House and Senate offices to push the FDA to act quicker to set duration limits on antibiotics used in agriculture. Included pitching a dear colleague sign on letter and also working with offices on their own letters to the FDA. We also worked to convince House/Senate offices to include more money for the FDA in the appropriations bill, and to include language in it that would force the FDA to move quicker. Supported consumer protections from surprise medical billing, especially ambulatory care.

LobbyistCovered position, as disclosed
KATIE MURTHA —
MATTHEW WELLINGTON —

Contacted: Consumer Product Safety Commission (CPSC); Securities & Exchange Commission (SEC); Federal Trade Commission (FTC); Office of the Comptroller of the Currency (OCC); Treasury, Dept of; Federal Deposit Insurance Corporation (FDIC); Labor, Dept of (DOL); White House Office; U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA); Federal Reserve System; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2229 (117th)

Budget/Appropriations BUD

Support right to repair and consumer protections in budget appropriations. Lobbied on the bipartisan infrastructure deal.

LobbyistCovered position, as disclosed
KATIE MURTHA —

Contacted: U.S. Trade Representative (USTR); Federal Deposit Insurance Corporation (FDIC); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Consumer Product Safety Commission (CPSC); Labor, Dept of (DOL); Federal Reserve System; Food & Drug Administration (FDA); Federal Trade Commission (FTC); White House Office; Office of the Comptroller of the Currency (OCC); SENATE

Consumer Issues/Safety/Products CSP

Participated in various meetings with CPSC Commissioners and FTC Commissioners on a variety of consumer protection issues, including safety recalls and data privacy law enforcement. 17 June 2021 Supported introduction of S2134, Data Protection Act (creating a Data Protection Agency), Gillibrand. 8 June 2021 Joined group letter to Senators opposing the efforts by large online retailers and importers to remove the COOL Online Act (Baldwin) from the U.S. Innovation and Competition Act (S. 1260). 17 May 2021 - Joined group letter to House Energy and Commerce leaders urging that any autonomous vehicle (AV) legislation ban companies use of forced arbitration clauses. 26 April 2021 Joined letter urging Senate Commerce and House Energy and Commerce leaders to swiftly enact legislation overturning adverse Supreme Court ruling and reinstating Federal Trade Commissions enforcement tools under the FTC Act, Section 13(b). 19 April 2021 Co-signed group letter from privacy groups to Senate Commerce leaders urging swift confirmation of Lina Khan to FTC. 9 April 2021 Co-signed USPIRG letter to Senate Commerce leaders urging swift confirmation of Lina Khan to FTC. 6 April 2021 Joined letter and participated in meetings with administration urging White House to nominate public interest advocates, consumer law scholars and other non-corporate attorneys to judicial and administrative positions.

LobbyistCovered position, as disclosed
EDMUND M MIERZWINSKI —

Contacted: Consumer Product Safety Commission (CPSC); Treasury, Dept of; U.S. Trade Representative (USTR); White House Office; Federal Deposit Insurance Corporation (FDIC); Labor, Dept of (DOL); Securities & Exchange Commission (SEC); Federal Reserve System; Federal Trade Commission (FTC); Food & Drug Administration (FDA); Office of the Comptroller of the Currency (OCC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1260 (117th)

Environment/Superfund ENV

Lobbied Rep Golden with Environment Maine for his support on the infrastructure bill, working to make sure they included clean car initiatives etc. in the final bill.

LobbyistCovered position, as disclosed
MATTHEW WELLINGTON —

Contacted: HOUSE OF REPRESENTATIVES; Consumer Product Safety Commission (CPSC); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Treasury, Dept of; Federal Deposit Insurance Corporation (FDIC); SENATE; Food & Drug Administration (FDA); White House Office; Labor, Dept of (DOL); Securities & Exchange Commission (SEC); Federal Reserve System; Office of the Comptroller of the Currency (OCC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.